3719 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 75 | next »
Genei
Gene descriptioni x
Protein classi x
Tissue
Cell
Pathology
Subcellular locationi x
Prognostic p-valuei x
RNA cancer categoryi x
RNA tissue categoryi x
A1BGAlpha-1-B glycoproteinPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Liver cancer: 3.97e-4
Tissue enrichedTissue enriched
A1CFAPOBEC1 complementation factorPredicted intracellular proteins
NucleoplasmTissue enrichedTissue enhanced
A4GNTAlpha-1,4-N-acetylglucosaminyltransferasePredicted secreted proteins
Group enrichedTissue enriched
AADACArylacetamide deacetylaseEnzymes
Predicted intracellular proteins
Ovarian cancer: 5.58e-6
Stomach cancer: 2.19e-4
Pancreatic cancer: 5.02e-4
Tissue enrichedGroup enriched
ABCA10ATP binding cassette subfamily A member 10Predicted intracellular proteins
Predicted membrane proteins
Transporters
MixedMixed
ABCA13ATP binding cassette subfamily A member 13Predicted membrane proteins
Vesicles
Centrosome
Cytosol
MixedTissue enriched
ABCA4ATP binding cassette subfamily A member 4Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Lung cancer: 2.45e-4
Urothelial cancer: 2.72e-4
Tissue enhancedTissue enhanced
ABCB1ATP binding cassette subfamily B member 1Cancer-related genes
CD markers
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Focal adhesion sites
Cytosol
Renal cancer: 2.95e-4
Pancreatic cancer: 3.33e-4
Tissue enhancedTissue enhanced
ABCB11ATP binding cassette subfamily B member 11Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol
Tissue enrichedTissue enriched
ABCC12ATP binding cassette subfamily C member 12Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhancedTissue enhanced
ABCC3ATP binding cassette subfamily C member 3Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Plasma membraneRenal cancer: 4.68e-6
Pancreatic cancer: 9.57e-4
MixedMixed
ABCC6ATP binding cassette subfamily C member 6Cancer-related genes
Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Plasma membraneLiver cancer: 3.82e-4
Tissue enhancedTissue enhanced
ABCC8ATP binding cassette subfamily C member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol
Tissue enrichedTissue enhanced
ABCC9ATP binding cassette subfamily C member 9Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Nucleoplasm
Cytosol
Renal cancer: 1.85e-5
MixedMixed
ABCD2ATP binding cassette subfamily D member 2Predicted membrane proteins
Transporters
Tissue enrichedTissue enhanced
ABCG5ATP binding cassette subfamily G member 5Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
NucleusLiver cancer: 2.60e-5
Tissue enrichedGroup enriched
ABCG8ATP binding cassette subfamily G member 8Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
VesiclesTissue enrichedGroup enriched
ABHD1Abhydrolase domain containing 1Predicted membrane proteins
Predicted secreted proteins
MixedTissue enriched
ABLIM2Actin binding LIM protein family member 2Predicted intracellular proteins
Nucleoplasm
Mitochondria
MixedTissue enhanced
ABOABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferasePredicted membrane proteins
MixedTissue enhanced
AC002429.5Predicted intracellular proteins
Tissue enrichedTissue enriched
AC006116.20Predicted secreted proteins
MixedTissue enriched
AC009014.3Predicted membrane proteins
Liver cancer: 1.63e-4
Pancreatic cancer: 6.13e-4
Tissue enhancedTissue enhanced
AC011513.3Predicted secreted proteins
Tissue enhancedGroup enriched
AC092835.2Predicted intracellular proteins
MixedMixed
AC113404.1Ras-related protein Rap-1b-like protein Predicted intracellular proteins
MixedTissue enriched
AC131097.4Predicted intracellular proteins
Tissue enhancedTissue enhanced
ACAD11Acyl-CoA dehydrogenase family member 11Predicted intracellular proteins
Tissue enhancedExpressed in all
ACADLAcyl-CoA dehydrogenase, long chainDisease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Renal cancer: 1.58e-11
Group enrichedTissue enhanced
ACANAggrecanPredicted intracellular proteins
Predicted secreted proteins
Renal cancer: 1.47e-6
MixedTissue enhanced
ACBD7Acyl-CoA binding domain containing 7Predicted intracellular proteins
Vesicles
Cytosol
MixedTissue enriched
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Renal cancer: 2.12e-5
Liver cancer: 4.21e-4
Tissue enhancedGroup enriched
ACER2Alkaline ceramidase 2Enzymes
Predicted membrane proteins
Tissue enhancedGroup enriched
ACKR2Atypical chemokine receptor 2G-protein coupled receptors
Predicted membrane proteins
Nucleoplasm
Vesicles
Cytosol
MixedTissue enhanced
ACKR4Atypical chemokine receptor 4G-protein coupled receptors
Predicted membrane proteins
Vesicles
Mitochondria
MixedMixed
ACMSDAminocarboxymuconate semialdehyde decarboxylaseEnzymes
Predicted intracellular proteins
Renal cancer: 2.39e-4
Group enrichedGroup enriched
ACOT12Acyl-CoA thioesterase 12Enzymes
Predicted intracellular proteins
Transporters
Nucleoplasm
Cytosol
Liver cancer: 5.30e-4
Tissue enrichedTissue enriched
ACOXLAcyl-CoA oxidase-likePredicted intracellular proteins
Nucleoli
Cytosol
Urothelial cancer: 6.48e-4
Group enrichedGroup enriched
ACPTAcid phosphatase, testicularDisease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
MixedTissue enhanced
ACRBPAcrosin binding proteinPredicted secreted proteins
Nucleoplasm
Vesicles
MixedTissue enriched
ACRV1Acrosomal vesicle protein 1Predicted secreted proteins
MixedTissue enriched
ACSL6Acyl-CoA synthetase long-chain family member 6Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedGroup enriched
ACSM1Acyl-CoA synthetase medium-chain family member 1Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Group enrichedTissue enriched
ACSM2AAcyl-CoA synthetase medium-chain family member 2AEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 1.41e-5
Group enrichedGroup enriched
ACSM2BAcyl-CoA synthetase medium-chain family member 2BEnzymes
Predicted intracellular proteins
Predicted membrane proteins
Liver cancer: 3.31e-4
Group enrichedGroup enriched
ACSM3Acyl-CoA synthetase medium-chain family member 3Enzymes
Predicted intracellular proteins
Renal cancer: 9.88e-6
Ovarian cancer: 1.97e-4
MixedTissue enhanced
ACSM6Acyl-CoA synthetase medium-chain family member 6Enzymes
Predicted membrane proteins
Urothelial cancer: 7.71e-4
Tissue enrichedTissue enhanced
ACSS3Acyl-CoA synthetase short-chain family member 3Enzymes
Predicted membrane proteins
MitochondriaRenal cancer: 0.00e+0
MixedMixed
ACTA1Actin, alpha 1, skeletal muscleDisease related genes
Plasma proteins
Predicted intracellular proteins
Group enrichedTissue enriched
ACTC1Actin, alpha, cardiac muscle 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Head and neck cancer: 3.72e-5
Urothelial cancer: 9.32e-4
Group enrichedTissue enriched
Page of 75 | next »